Should we treat high-normal blood pressure?
- PMID: 12359985
- DOI: 10.1097/00004872-200210000-00026
Should we treat high-normal blood pressure?
Abstract
Objectives: To examine the risk of cardiovascular disease associated with high-normal blood pressure in English adults and estimate the proportion of these individuals who are at high cardiovascular risk.
Design and setting: Cross-sectional survey of England in 1998.
Participants: Nationally representative sample of 12,341 individuals aged 18-80 years living in private households in England.
Main outcome measure: Percentage of individuals with high-normal blood pressure who have cardiovascular disease, diabetes mellitus or a 10-year cardiovascular event risk of at least 20%.
Results: Of the 12,341 participants, 2413 (19.6%) had high-normal blood pressure. About 5.3% of those aged 18-80 years with high-normal blood pressure had cardiovascular disease or diabetes, and a further 7.6% were at a predicted cardiovascular event risk of at least 20% over 10 years. The mean predicted risk was 8.7% for men and 6.3% for women in the high-normal blood pressure category. The majority of men aged 61-80 years were at high cardiovascular risk. On average, men and women with high-normal blood pressure had a greater incidence of cardiovascular disease and diabetes mellitus, and a greater predicted mean cardiovascular risk than those with normal blood pressure. Extending antihypertensive treatment to individuals with high-normal blood pressure who are at high cardiovascular risk would involve treating an additional 2.5% of the English population aged 18-80 years.
Conclusion: These findings support the view that individuals with high-normal blood pressure at high risk for cardiovascular disease should be targeted for blood pressure-lowering treatment.
Comment in
-
Lowering blood pressure for cardiovascular risk reduction: moving the goalposts or spreading the net?J Hypertens. 2002 Oct;20(10):1945-8. doi: 10.1097/00004872-200210000-00011. J Hypertens. 2002. PMID: 12359970 No abstract available.
Similar articles
-
Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care.J Hypertens. 2004 Jan;22(1):51-7. doi: 10.1097/00004872-200401000-00012. J Hypertens. 2004. PMID: 15106794
-
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538. J Hum Hypertens. 2003. PMID: 12714973
-
Ethnic subgroup differences in hypertension in Pakistan.J Hypertens. 2003 May;21(5):905-12. doi: 10.1097/00004872-200305000-00014. J Hypertens. 2003. PMID: 12714864
-
Central aortic pressure and clinical outcomes.J Hypertens. 2009 Jun;27(6):1123-5. doi: 10.1097/HJH.0b013e32832b6566. J Hypertens. 2009. PMID: 19454902 Review. No abstract available.
-
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis.Hypertension. 2016 Apr;67(4):693-700. doi: 10.1161/HYPERTENSIONAHA.115.06981. Epub 2016 Feb 22. Hypertension. 2016. PMID: 26902495 Review.
Cited by
-
The natural history of hypertension: prehypertension or masked hypertension?J Clin Hypertens (Greenwich). 2007 Oct;9(10):807-10. doi: 10.1111/j.1751-7176.2007.tb00011.x. J Clin Hypertens (Greenwich). 2007. PMID: 17917511 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources